Analyst Downgrades – NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) Stock Gets Downgraded By LADENBURG THALM/SH SH from Buy ➝ Neutral to

Analyst Ratings For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)

Story continues below

Today, NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) stock was downgraded by LADENBURG THALM/SH SH from Buy ➝ Neutral to with a price target of $33.00.

Some recent analyst ratings include

  • 6/13/2018-LADENBURG THALM/SH SH was Downgraded by analysts at LADENBURG THALM/SH SH from a “Buy ➝ Neutral” rating to a “” rating. They now have a $33.00 price target on the stock.
  • 3/8/2018-Piper Jaffray Companies Reiterated Rating of Hold.
  • 1/8/2018-Barclays Reiterated Rating of Sell.
  • 12/20/2017-William Blair was Downgraded by analysts at William Blair from a “Outperform ➝ Market Perform” rating to a “” rating.
  • 12/13/2017-JPMorgan Chase & Co. was Downgraded by analysts at JPMorgan Chase & Co. from a “Neutral ➝ Underweight” rating to a “” rating. They now have a $25.00 price target on the stock.

Recent Insider Trading Activity For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) has insider ownership of 45.80% and institutional ownership of 89.90%.

  • On 6/4/2018 James J. Vaughn, Insider, sold 93,414 with an average share price of $45.78 per share and the total transaction amounting to $4,276,492.92.
  • On 5/14/2018 Kimberly J. Popovits, CEO, sold 10,000 with an average share price of $38.09 per share and the total transaction amounting to $380,900.00.
  • On 5/9/2018 Steven Shak, Insider, sold 5,500 with an average share price of $36.64 per share and the total transaction amounting to $201,520.00.
  • On 5/2/2018 James J. Vaughn, Insider, sold 1,497 with an average share price of $32.50 per share and the total transaction amounting to $48,652.50.
  • On 4/16/2018 Kimberly J. Popovits, Insider, sold 15,000 with an average share price of $33.19 per share and the total transaction amounting to $497,850.00.
  • On 3/13/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.80 per share and the total transaction amounting to $164,000.00.
  • On 2/20/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.89 per share and the total transaction amounting to $164,450.00.

Recent Trading Activity for NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
Shares of NASDAQ:GHDX – Genomic Health closed the previous trading session at 49.68 down -1.02 2.01% with 48.849998474121094 shares trading hands.

An ad to help with our costs